10-K Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001079974-15-000209`
Period End Date	20141231
Filing Date	20150331
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	spzr-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 44 Income Statement 16 Cash Flow Statement 31 Stockholders Equity 12

Balance Sheet 44 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.08K	USD	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	-	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$4.47K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$5.08K	USD	Point-in-time
Total Assets	`Assets`	$5.08K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total Assets	`Assets`	$4.47K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	12.14M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	15.41M	shares	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$8.96K	USD	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$22.70K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	12.14M	shares	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	15.41M	shares	Point-in-time
Loans from Stockholders	`DueToOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Loans from Stockholders	`DueToOfficersOrStockholdersCurrent`	$2.00K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$8.96K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$24.70K	USD	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 15,409,999 and 12,142,025 shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively	`CommonStockValue`	$121.42K	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 15,409,999 and 12,142,025 shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively	`CommonStockValue`	$171.42K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.39M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.43M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-20.07K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-20.23K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-3.87K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$4.47K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$5.08K	USD	Point-in-time

Income Statement 16 line items

Line Item	Tag	Value	Unit	Period
General and Administrative	`GeneralAndAdministrativeExpense`	$-27.21K	USD	Annual
General and Administrative	`GeneralAndAdministrativeExpense`	$-32.81K	USD	Annual
Total Operating Expenses	`OperatingIncomeLoss`	$32.81K	USD	Annual
Total Operating Expenses	`OperatingIncomeLoss`	$27.21K	USD	Annual
Other Income	`OtherIncome`	$28.50K	USD	Annual
Other Income	`OtherIncome`	-	USD	Annual
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.29K	USD	Annual
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-32.81K	USD	Annual
Income Taxes	`IncomeTaxExpenseBenefit`	$833.00	USD	Annual
Income Taxes	`IncomeTaxExpenseBenefit`	$1.45K	USD	Annual
Net Loss	`NetIncomeLoss`	$-161.00	USD	Annual
Net Loss	`NetIncomeLoss`	$-33.64K	USD	Annual
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	Annual
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.24M	shares	Annual

Cash Flow Statement 31 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-161.00	USD	Annual
Net Loss	`NetIncomeLoss`	$-33.64K	USD	Annual
Gain on forgiveness of debt	`DebtInstrumentDecreaseForgiveness`	$-28.50K	USD	Annual
Gain on forgiveness of debt	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Decrease in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$4.22K	USD	Annual
Increase (decrease) in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$5.03K	USD	Annual
Increase (decrease) in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-13.74K	USD	Annual
Advances from officers	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Advances from officers	`ProceedsFromRelatedPartyDebt`	$2.00K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-43.16K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.63K	USD	Annual
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$50.00K	USD	Annual
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$100.00K	USD	Annual
Redemption of common stock	`StockRedeemedOrCalledDuringPeriodValue`	-	USD	Annual
Redemption of common stock	`StockRedeemedOrCalledDuringPeriodValue`	$-100.00K	USD	Annual
Proceeds from (repayment of) loans from officers	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-2.00K	USD	Annual
Proceeds from (repayment of) loans from officers	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$20.50K	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$48.00K	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$20.50K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.38K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.13K	USD	Annual
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.08K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.08K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Income Taxes	`IncomeTaxesPaid`	$833.00	USD	Annual
Income Taxes	`IncomeTaxesPaid`	$1.45K	USD	Annual

Stockholders Equity 12 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, value	`StockholdersEquity`	$-20.07K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-20.23K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-3.87K	USD	Point-in-time
Common stock issued for cash, value	`StockIssuedDuringPeriodValueOther`	$100.00K	USD	Annual
Common stock issued for cash, value	`StockIssuedDuringPeriodValueOther`	$50.00K	USD	Annual
Redemption of common stock, value	`StockRedeemedOrCalledDuringPeriodValue`	-	USD	Annual
Redemption of common stock, value	`StockRedeemedOrCalledDuringPeriodValue`	$-100.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-161.00	USD	Annual
Net loss	`NetIncomeLoss`	$-33.64K	USD	Annual
Ending Balance, value	`StockholdersEquity`	$-20.07K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-20.23K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-3.87K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.